These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20210540)

  • 1. Acceptability of PrEP for HIV prevention among women at high risk for HIV.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; Macqueen KM
    J Womens Health (Larchmt); 2010 Apr; 19(4):791-8. PubMed ID: 20210540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru.
    Peinado J; Lama JR; Galea JT; Segura P; Casapia M; Ortiz A; Montano SM; Kochel T; Sánchez J
    J Int Assoc Provid AIDS Care; 2013; 12(4):278-83. PubMed ID: 23422742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM
    Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Curlin ME; Na-Pompet S; Warapronmongkholkul A; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Choopanya K;
    AIDS; 2015 Apr; 29(7):819-24. PubMed ID: 25985403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and attitudes about preexposure prophylaxis among seronegative partners and the potential of sexual disinhibition.
    Tripathi A; Whiteside YO; Duffus WA
    South Med J; 2013 Oct; 106(10):558-64. PubMed ID: 24096949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure chemoprophylaxis of HIV infection: quo vadis?
    Clercq ED
    Biochem Pharmacol; 2012 Mar; 83(5):567-73. PubMed ID: 22067069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.
    Lorente N; Fugon L; Carrieri MP; Andreo C; Le Gall JM; Cook E; Aboulker JP; Capitant C; Molina JM; Spire B
    AIDS Care; 2012; 24(4):468-77. PubMed ID: 22085083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performative function of expectations in translating treatment to prevention: the case of HIV pre-exposure prophylaxis, or PrEP.
    Rosengarten M; Michael M
    Soc Sci Med; 2009 Oct; 69(7):1049-55. PubMed ID: 19695756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India.
    Safren SA; Kumarasamy N; Hosseinipour M; Harwood MM; Hoffman I; McCauley M; Jumbe A; Nyirenda C; Mimiaga MJ; Solomon S; Celentano D; Mayer KH
    AIDS Behav; 2006 Jul; 10(4):443-50. PubMed ID: 16604297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pre-exposure prophylaxis for HIV prevention.
    García-Lerma JG; Paxton L; Kilmarx PH; Heneine W
    Trends Pharmacol Sci; 2010 Feb; 31(2):74-81. PubMed ID: 19963288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HIV preexposure prophylaxis].
    Olczak A; Grabczewska E
    Przegl Epidemiol; 2012; 66(1):79-82. PubMed ID: 22708303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.
    van der Straten A; Mayo A; Brown ER; Amico KR; Cheng H; Laborde N; Marrazzo J; Torjesen K
    AIDS Behav; 2015 May; 19(5):770-83. PubMed ID: 25384907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.
    Corneli A; Perry B; Agot K; Ahmed K; Malamatsho F; Van Damme L
    PLoS One; 2015; 10(4):e0125458. PubMed ID: 25867624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability in microbicide and PrEP trials: current status and a reconceptualization.
    Mensch BS; van der Straten A; Katzen LL
    Curr Opin HIV AIDS; 2012 Nov; 7(6):534-41. PubMed ID: 23032737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine acceptability: a systematic review and meta-analysis.
    Newman PA; Logie C
    AIDS; 2010 Jul; 24(11):1749-56. PubMed ID: 20597165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicide researchers are focusing on adherence strategies as setbacks mount. IAS conference held uninspiring news.
    AIDS Alert; 2007 Sep; 22(9):97-9. PubMed ID: 18411459
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.
    Andelin CO; Drobnis EZ; Schust DJ
    Obstet Gynecol; 2010 Jul; 116(1):194-195. PubMed ID: 20567190
    [No Abstract]   [Full Text] [Related]  

  • 19. Handheld computers to run ACASI to assess HIV risk and deliver tailored soap opera video feedback: acceptability among young adult urban women.
    Jones R
    J Assoc Nurses AIDS Care; 2012; 23(3):260-7. PubMed ID: 21664834
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceptability of and compliance with a probiotic capsule intervention in pregnancy.
    Lindsay KL; Brennan L; McAuliffe FM
    Int J Gynaecol Obstet; 2014 Jun; 125(3):279-80. PubMed ID: 24636629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.